A woman demands P100 million after doctors attributed the diagnosis of Guillain-Barre Syndrome to the Covid vaccine
A 39-year-old Argentine woman has begun legal proceedings against… AstraZeneca and the country's government after experiencing alleged negative effects from the Covid vaccine. Information from the newspaper No nation Published this Tuesday (May 14, 2024)
The case, pending in federal court since January 2022, seeks P100 million in damages. Neurologists were supposed to diagnose the woman with Guillain-Barre Syndrome and link her to the Covid vaccine. The disease could have led to quadriplegia.
The woman claims that she was subjected to social and work pressure to get vaccinated. After taking the dose, she began to feel severe pain and weakness in her legs, which quickly developed into an inability to stand.
The process includes compensation for moral damages, disability and loss of quality of life. The accusation also points to the direct connection between vaccination with AstraZeneca and the inability to work.
the other side
In a note sent to No nationThe pharmaceutical company said it does not comment on ongoing operations.
“At AstraZeneca, we do not comment on ongoing litigation. We extend our deepest condolences to anyone who has lost a loved one or reported health problems. Patient safety is our top priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.”He said.
AstraZeneca admits 'rare adverse effect'
AstraZeneca has admitted for the first time in court that its Covid-19 vaccine can cause a virus “Rare negative effect”.
According to the British newspaper Telegraphthe pharmaceutical company is the target of a class action in which 51 families are demanding compensation of up to 100 million pounds sterling (about 650 million Brazilian reals).
Oliver Ashford is a contributor to Mediarunsearch.co.uk, covering a broad range of topics including news, politics, business, technology, sport, entertainment and lifestyle. He focuses on delivering clear, balanced reporting that helps readers stay informed about current affairs and developments that matter. With an emphasis on accuracy, relevance and accessibility, Oliver aims to present useful information and engaging stories in a straightforward manner, making complex topics easier for readers to understand and follow.